110 related articles for article (PubMed ID: 667789)
1. Pretreatment radiographic evaluation of patients with malignant melanoma.
Meyer JE; Stolbach L
Cancer; 1978 Jul; 42(1):125-6. PubMed ID: 667789
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of staging chest radiographs and serum lactate dehydrogenase for localized melanoma.
Wang TS; Johnson TM; Cascade PN; Redman BG; Sondak VK; Schwartz JL
J Am Acad Dermatol; 2004 Sep; 51(3):399-405. PubMed ID: 15337983
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of full-lung tomography in the detection of early metastatic disease from melanoma.
Curtis AM; Ravin CE; Deering TF; Putman CE; McLoud TC; Greenspan RH
Radiology; 1982 Jul; 144(1):27-9. PubMed ID: 7089262
[TBL] [Abstract][Full Text] [Related]
4. Computed tomography in evaluation of patients with stage III melanoma.
Kuvshinoff BW; Kurtz C; Coit DG
Ann Surg Oncol; 1997; 4(3):252-8. PubMed ID: 9142387
[TBL] [Abstract][Full Text] [Related]
5. Findings of computed tomography in stage IIB and IIC melanoma: a six-year retrospective study in the South-East of Scotland.
Orfaniotis G; Mennie JC; Fairbairn N; Butterworth M
J Plast Reconstr Aesthet Surg; 2012 Sep; 65(9):1216-9. PubMed ID: 22525255
[TBL] [Abstract][Full Text] [Related]
6. Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma.
Clark PB; Soo V; Kraas J; Shen P; Levine EA
Arch Surg; 2006 Mar; 141(3):284-8. PubMed ID: 16549694
[TBL] [Abstract][Full Text] [Related]
7. Is there an indication for routine chest X-ray in initial staging of melanoma?
Vermeeren L; van der Ent FW; Hulsewé KW
J Surg Res; 2011 Mar; 166(1):114-9. PubMed ID: 19691983
[TBL] [Abstract][Full Text] [Related]
8. Detection of metastatic malignant melanoma by chest roentgenography.
Simeone JF; Putman CE; Greenspan RH
Cancer; 1977 May; 39(5):1993-6. PubMed ID: 858128
[TBL] [Abstract][Full Text] [Related]
9. Current role of immunoscintigraphy in malignant melanoma follow-up. A study of 114 patients.
Ribuffo D; Cavalieri L; De Vita F; Massa R; Prosperi D; Tuccimei M; Scuderi N
J Exp Clin Cancer Res; 2001 Mar; 20(1):11-5. PubMed ID: 11370816
[TBL] [Abstract][Full Text] [Related]
10. Radiographic evaluation of metastatic melanoma.
Meyer JE
Cancer; 1978 Jul; 42(1):127-32. PubMed ID: 667790
[TBL] [Abstract][Full Text] [Related]
11. Clinical value of including the head and lower extremities in 18F-FDG PET/CT imaging for patients with malignant melanoma.
Niederkohr RD; Rosenberg J; Shabo G; Quon A
Nucl Med Commun; 2007 Sep; 28(9):688-95. PubMed ID: 17667747
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of radiographic staging in patients diagnosed with AJCC stage III melanoma.
Pandalai PK; Dominguez FJ; Michaelson J; Tanabe KK
Ann Surg Oncol; 2011 Feb; 18(2):506-13. PubMed ID: 20734149
[TBL] [Abstract][Full Text] [Related]
13. 3'-18F-fluoro-3'-deoxy-L-thymidine: a new tracer for staging metastatic melanoma?
Cobben DC; Jager PL; Elsinga PH; Maas B; Suurmeijer AJ; Hoekstra HJ
J Nucl Med; 2003 Dec; 44(12):1927-32. PubMed ID: 14660718
[TBL] [Abstract][Full Text] [Related]
14. Futility of positron emission tomography and other modalities in the initial radiographic screening of patients with melanoma.
Miranda EP
Arch Surg; 2006 Oct; 141(10):1050. PubMed ID: 17043288
[No Abstract] [Full Text] [Related]
15. Sigma-receptor imaging by means of I123-IDAB scintigraphy: clinical application in melanoma and non-small cell lung cancer.
Everaert H; Flamen P; Franken PR; Verhaeghe W; Bossuyt A
Anticancer Res; 1997; 17(3B):1577-82. PubMed ID: 9179197
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of high-risk melanoma: comparison of [18F]FDG PET and high-dose 67Ga SPET.
Kalff V; Hicks RJ; Ware RE; Greer B; Binns DS; Hogg A
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):506-15. PubMed ID: 11914889
[TBL] [Abstract][Full Text] [Related]
17. Thoracic metastasis in malignant melanoma. A radiographic survey of 65 patients.
Webb WR; Gamsu G
Chest; 1977 Feb; 71(2):176-81. PubMed ID: 832488
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of (18)F-FDG-PET/CT in early and late stages of high-risk cutaneous malignant melanoma.
Gellén E; Sántha O; Janka E; Juhász I; Péter Z; Erdei I; Lukács R; Fedinecz N; Galuska L; Remenyik É; Emri G
J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1938-44. PubMed ID: 25753249
[TBL] [Abstract][Full Text] [Related]
19. Detection of metastases in patients with cutaneous melanoma using FDG-PET/CT.
Akcali C; Zincirkeser S; Erbagcý Z; Akcali A; Halac M; Durak G; Sager S; Sahin E
J Int Med Res; 2007; 35(4):547-53. PubMed ID: 17697533
[TBL] [Abstract][Full Text] [Related]
20. The value of staging and serial follow-up investigations in patients with completely resected, primary, cutaneous malignant melanoma.
Kersey PA; Iscoe NA; Gapski JA; Osoba D; From L; DeBoer G; Quirt IC
Br J Surg; 1985 Aug; 72(8):614-7. PubMed ID: 4027532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
